The liver directs cholesterol metabolism in the organism.All the major fluxes of cholesterol within the body involve the liver:dietary cholesterol is directed to the liver;cholesterol from peripheral cells goes to the liver;the liver is a major site of cholesterol synthesis for the organism;cholesterol is secreted from the liver within the bile,within apoB lipoproteins and translocated to nascent HDL.The conventional model of cholesterol homeostasis posits that cholesterol from any source enters a common,rapidly exchangeable pool within the cell,which is in equilibrium with a regulatory pool.Increased influx of cholesterol leads rapidly to decreased synthesis of cholesterol.This model was developed based on in vitro studies in the fibroblast and validated only for LDL particles.The challenges the liver must meet in vivo to achieve cholesterol homeostasis are far more complex.Our model posits that the cholesterol derived from three different lipoproteins endosomes has three different fates:LDL-derived cholesterol is largely recycled within VLDL with most of the cholesterol shunted through the hepatocyte without entering the exchangeable pool of cholesterol;high density lipoprotein-derived CE is transcytosed into bile;and chylomicron remnant-derived cholesterol primarily enters the regulatory pool within the hepatocyte.These endosomal channels represent distinct physiological pathways and hepatic homeostasis represents the net result of the outcomes of these distinct channels.Our model takes into account the distinct physiological challenges the hepatocyte must meet,underlie the pathophysiology of many of the apoB dyslipoproteinemias and account for the sustained effectiveness of therapeutic agents such as statins. The liver directs cholesterol metabolism in the organism. All major fluxes of cholesterol within the body involve the liver: dietary cholesterol is directed to the liver; cholesterol from peripheral cells goes to the liver; the liver is a major site of cholesterol synthesis for the organism; cholesterol is secreted from the liver within the bile, within apoB lipoproteins and translocated to nascent HDL. The conventional model of cholesterol homeostasis posits that cholesterol from any source enters a common, rapidly exchangeable pool within the cell, which is in equilibrium with a regulatory pool. Increased of cholesterol leads rapidly to decreased synthesis of cholesterol. This model was developed based on in vitro studies in the fibroblast and validated only for LDL particles. challenges the liver must meet in vivo to achieve cholesterol homeostasis are far more complex .Our model posits that the cholesterol derived from three different lipoproteins endosomes has three different fa tes: LDL-derived cholesterol is dominant recycled within VLDL with most of the cholesterol shunted through the hepatocyte without entering the exchangeable pool of cholesterol; high density lipoprotein-derived CE is transcytosed into bile; and chylomicron remnant- within the hepatocyte. These endosomal channels represent distinct physiological pathways and hepatic homeostasis represents the net result of the outcomes of these distinct channels. Our model takes into account the distinct physiological challenges of the hepatocyte must meet, underlie the pathophysiology of many of the apoB dyslipoproteinemias and account for the sustained effectiveness of therapeutic agents such as statins.